[1]Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science, 1989, 244(4902): 359–362. <\p>

[2]Kang SM, Choi SH, Park CY, Kim MH, Kim TK, Park JM, Koh MS, Kang HJ, Hwang SB. Monoclonal antibody rec-ognizing N-terminal epitope of hepatitis C virus non-structural 5B inhibits viral RNA replication. J Viral Hepat, 2008, 15(4): 305–313. <\p>

[3]Penin F, Dubuisson J, Rey FA, Moradpour D, Pawlotsky JM. Structural biology of hepatitis C virus. Hepatology, 2004, 39(1): 5–19.<\p>

[4]Hatziapostolou M, Polytarchou C, Aggelidou E, Drakaki A, Poultsides GA, Jaeger SA, Ogata H, Karin M, Struhl K, Hadzopoulou-Cladaras M, Iliopoulos. An HNF4α-miRNA inflammatory feedback circuit regulates hepatocellular on cogenesis. Cell, 2011, 147(6): 1233–1247.<\p>

[5]Easton DF, Pooley KA, Dunning AM. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature, 2007, 447(7148): 1087–1093.<\p>

[6]Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM, Perry JR, Elliott KS, Lango H, Rayner NW, Shields B, Harries LW, Barrett JC, Ellard S, Groves CJ, Knight B, Patch AM, Ness AR, Ebrahim S, Lawlor DA, Ring SM, Ben-Shlomo Y, Jarvelin MR, Sovio U, Bennett AJ, Melzer D, Ferrucci L, Loos RJ, Barroso I, Wareham NJ, Karpe F, Owen KR, Cardon LR, Walker M, Hitman GA, Palmer CN, Doney AS, Morris AD, Smith GD, Hattersley AT, McCarthy MI. A common variant in the FTO gene is associated with body mass index and predis-poses to childhood and adult obesity. Science, 2007, 316(5826): 889–894.<\p>

[7]Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, Duren WL, Erdos MR, Stringham HM, Chines PS, Jack-son AU, Prokunina-Olsson L, Ding CJ, Swift AJ, Narisu N, Hu TL, Pruim R, Xiao R, Li XY, Conneely KN, Riebow NL, Sprau AG, Tong M, White PP, Hetrick KN, Barnhart MW, Bark CW, Goldstein JL, Watkins L, Xiang F, Sara-mies J, Buchanan TA, Watanabe RM, Valle TT, Kinnunen L, Abecasis GR, Pugh EW, Doheny KF, Bergman RN, Tuomilehto J, Collins FS, Boehnke M. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science, 2007, 316(5829): 1341–1345.<\p>

[8]Kanda T, Wu S, Kiyohara T, Nakamoto S, Jiang X, Miya-mura T, Imazeki F, Ishii K, Wakita T, Yokosuka O. Inter-leukin-29 suppresses hepatitis A and C viral internal ribo-somal entry site-mediated translation. Viral Immunol, 2012, 25(5): 379–386.<\p>

[9]Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, Shah NK, Langer JA, Sheikh F, Dickensheets H, Donnelly RP. IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol, 2003, 4(1): 69–77.<\p>

[10]Sheppard P, Kindsvogel W, Xu WF, Henderson K, Schlutsmeyer S, Whitmore TE, Kuestner R, Garrigues U, Birks C, Roraback J, Ostrander C, Dong D, Shin J, Pres-nell S, Fox B, Haldeman B, Cooper E, Taft D, Gilbert T, Grant FJ, Tackett M, Krivan W, McKnight G, Clegg C, Foster D, Klucher KM. IL-28, IL-29 and their class II cy-tokine receptor IL-28R. Nat Immunol, 2003, 4(1): 63–68.<\p>

[11]Prokunina-Olsson L, Muchmore B, Tang W, Pfeiffer RM, Park H, Dickensheets H, Hergott D, Porter-Gill P, Mumy A, Kohaar I, Chen S, Brand N, Tarway M, Liu L, Sheikh F, Astemborski J, Bonkovsky HL, Edlin BR, Howell CD, Morgan TR, Thomas DL, Rehermann B, Donnelly RP, O'Brien TR. A variant upstream of IFNL3 (IL28B) creat-ing a new interferon gene IFNL4 is associated with im-paired clearance of hepatitis C virus. Nat Genet, 2013, 45(2): 164–171.<\p>

[12]Pestka S, Krause CD, Walter MR. Interferons, inter-feron-like cytokines, and their receptors. Immunol Rev, 2004, 202(1): 8–32.<\p>

[13]Gad HH, Dellgren C, Hamming OJ, Vends S, Paludan SR,